Explore more publications!

Press Releases

Nasus Pharma Announces Positive Interim Results from Phase 2 Clinical Study of NS002 Intranasal Epinephrine Powder
Israel Opens Supercomputer Access, Offering Discounted Nvidia B200 GPUs Accelerators to High-Tech Comp. and Researchers
PRF Technologies Files Its First Patent Application for Solar Plant Micro-Climate Forecast Modeling Designed to Improve Energy Production Forecast Accuracy
InspireMD Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Can-Fite Completes Patient Enrollment in Phase 2a Pancreatic Cancer Study of Namodenoson
Pomerantz Law Firm Announces the Filing of a Class Action Against SLM Corporation and Certain Officers – SLM
Gaza Suffering Deepens as Respiratory Virus Kills Dozens

Gaza Suffering Deepens as Respiratory Virus Kills Dozens

Israel Begins Severing Power, Water to UNRWA Facilities

Israel Begins Severing Power, Water to UNRWA Facilities

Israel cuts utilities to UNRWA facilities in East Jerusalem

Israel cuts utilities to UNRWA facilities in East Jerusalem

Israel murders three Palestinians in new assaults on Gaza

Israel murders three Palestinians in new assaults on Gaza

PainReform Ltd. Changes Name to PRF Technologies Ltd. Reflecting Expansion into Diversified Healthcare and AI-Driven Energy Platforms
Ambient Computing Market Poised for Rapid Growth, Expected to Reach USD 438 Billion by 2033, says Coherent Market Insights
Israeli Attacks in Gaza Kill Three Palestinians

Israeli Attacks in Gaza Kill Three Palestinians

Israeli attacks in Gaza kill three despite ceasefire

Israeli attacks in Gaza kill three despite ceasefire

Israeli raids in West Bank leave one dead, mosque besieged

Israeli raids in West Bank leave one dead, mosque besieged

Tower Semiconductor Announces Fourth Quarter and Fiscal Year 2025 Financial Results and Conference Call
European Left MEPs push to suspend EU-Israel pact over Gaza concerns

European Left MEPs push to suspend EU-Israel pact over Gaza concerns

AJOVY® (fremanezumab-vfrm) Significantly Reduced Monthly Migraine and Headache Days in Children and Adolescents with Episodic Migraine Compared to Placebo in the SPACE Trial; Results Published in New England Journal of Medicine
Transformation Insights Announces Global Office in Tel Aviv, Israel
Clearmind Medicine Announces Successful Completion of Treatment in All Patients of the Second Cohort in Ongoing Phase I/IIa Clinical Trial for CMND-100

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions